ArticleScientific reports2021

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC.

Motohiro Tamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.